Keywords: MAPK; ADCC; antibody-dependent cell-mediated cytotoxicity; AKT; protein kinase B; ATP; adenosine triphosphate; cfDNA; circulating free DNA; CISH; chromogenic in-situ hybridization; CTC; circulating tumor cells; EGFR; epithelial growth factor receptor; EMT; epit
مقالات ISI MAPK (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MAPK; AZ; acetazolamide; IM; imatinib; EAC; Ehrlich ascites carcinoma; PDGF-A; platelet derived growth factor-A; TSP-1; thrombospondin-1; VEGF; vascular endothelial growth factor; NO; nitric oxide; MMP; matrix metalloproteinase; MAPK; mitogen activated protein
Keywords: MAPK; CFU; colony forming units; EPS; extracellular polysaccharide; GIT; gastrointestinal tract; GM-CSF; granulocyte macrophage colony-stimulating factor; ETEC; enterotoxigenic E. coli; FOS; fructo-oligosaccharide; GOS; galacto-oligosaccharide; HSP; heat shock
Keywords: MAPK; MAPK; mitogen-activated protein kinase; Actn2; actinin alpha 2; AMPK; adenosine monophosphate-activated protein kinase; Atf3; activating transcription factor 3; ATP; Adenosine triphosphate; b2MG; Beta-2-microglobulin; Bcl11a; B-cell CLL/lymphoma 11A; Bcl2
Keywords: MAPK; Thyroid hormones; 3, 5-Diiodothyronine; 3-Iodothyronamine; Thyroacetic acids; Non-genomic effects; Cardioprotection; ADP; adenosine diphosphate; Akt; Ak strain transforming; Ang II; angiotensin II; ATP; adenosine triphosphate; CaM; calmodulin; D2; type II
Keywords: MAPK; AVD; aortic valve disease; βGP; beta-glycerophosphate; HAS; hyaluronan synthase; HYAL; hyaluronidase; IαI; Inter-alpha-Inhibitor; MAPK; mitogen-activated protein kinase; PDMS; polydimethylsiloxane; RHAMM; the receptor for hyaluronan mediated motility; T
Keywords: MAPK; â¢OH; hydroxyl radical; 2,2-BP; 2,2-bipyridyl; ABC; ATP-binding cassette; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; AMPKK; AMPK kinase; ANT; adenine nucleotide translocase; AP-1; activator protein 1; Apaf-1; protease activating
Keywords: MAPK; Aldose reductase inhibitors; 1-Hydroxypyrazole; Trifluoroacetylation; Sorbitol accumulation; Differential inhibitors; ALR2; aldose reductase; ALR1; aldehyde reductase; AP-1; activator protein 1; ARIs; aldose reductase inhibitors; DHN; 1,4-dihydroxynonene;
Keywords: MAPK; Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: MAPK; ADP; adenosine diphosphate; AMP; adenosine monophosphate; ATP; adenosine triphosphate; [Ca2+]i; intracellular calcium concentration; CaM; calmodulin; CaMKII; Ca2+/calmodulin-dependent kinase II; cAMP; cyclic adenosine monophosphate; COX-2; cyclooxygenase-
Keywords: MAPK; Aptamer; Apoptosis; Targeted therapy; Intrinsic apoptosis pathway; Extrinsic apoptosis pathway; Intramer; Akt; PKB (protein kinase B); Bcl; B-cell lymphoma family protein; BH; Bcl-2 homology domain; Bmi-1; B lymphoma Mo-MLV insertion region 1; CD; cluster
Keywords: MAPK; AML; acute myeloid leukemia; CAK; CDK-activating kinase; CDK; cyclin-dependent kinases; CLL; chronic lymphocytic leukemia; CT; RNA polymerase II C-terminal domain; DLT; dose-limiting toxicities; DSIF; DRB-sensitivity inducing factor; ER; estrogen Receptor
Keywords: MAPK; Inflammation; Bipolar disorder; Mania; Depression; Biomarkers; ADHD; Attention Deficit Hyperactivity Disorder; ANCOVA; Analysis of Covariance; AITD; Autoimmune Thyroid Disease; α1-AT; α1-Antitrypsin; α1S; α1 Acid glycoprotein; BA; Broadmann's Area; BA
Keywords: MAPK; 7AAD; 7-aminoactinomycin D; αSMA; alpha smooth muscle actin; AKT; protein kinase B; ALK; activin receptor-like kinase; Ang; angiopoietin; Ang II; angiotensin II; BCRP1; breakpoint cluster region pseudogene; bFGF; basic fibroblast growth factor; C1P; cera
Keywords: MAPK; ELF-EMF; extremely low frequency electromagnetic fields; EMF; electromagnetic fields; RF; Radiofrequency; ROS; reactive oxygen species; VGCCs; voltage-gated calcium channels; MAPK; mitogen-activated phosphokinase; NF-κB; nuclear factor kappa B; ERK- 1/2;
Keywords: MAPK; Stomach Cancer; Mouse Model; Cancer Stem Cell; Oncogene; EGFP; enhanced green fluorescent protein; EYFP; enhanced yellow fluorescent protein; LSL; Lox-Stop-Lox; MAPK; mitogen-activated protein kinases; TG; transgenic;
Keywords: MAPK; Peripheral blood mononuclear cells; AMP-activated protein kinase; Postprandial lipemia; Nuclear factor-κB; ACC; Acetyl-CoA carboxylase; AICAR; 5-Aminoimidazole-4-carboxamide ribonucleotide; AMPK; AMP activated protein kinase; ANOVA; Analysis of variance;
Keywords: MAPK; Ovarian cancer; Chemotherapy resistance; Natural compounds; Autophagy; Apoptosis; Ovarian cancer stem-like cells; ABCG2; ATP-binding cassette G2; AE; Amla extracts; Akt; protein kinase B; ALDH1; aldehyde dehydrogenase 1; ARE; antioxidant-response element;
Keywords: MAPK; TIO; tumor-induced osteomalacia; FGF23; fibroblast growth factor 23; 1,25-OH2-vitamin D; 1,25(OH)2D; FGFR1; fibroblast growth factor receptor-1; PTH; parathyroid hormone; TmP/GFR; tubular maximum reabsorption of phosphate to glomerular filtration rate; FD
Keywords: MAPK; DAMP; damage associated molecular pattern; LPS; lipopolysaccharide; MAPK; mitogen-activated protein kinase; MyD88; myeloid differentiation primary response gene 88; NF-κB; nuclear factor kappa B; NLR; nucleotide-binding domain and leucine-rich repeat; NO
Keywords: MAPK; PPI; protein-protein interaction; ACTA2; Actin, Alpha 2, Smooth Muscle, Aorta; ACTN1; Actinin, Alpha 1; VCL; Vinculin; CCND1; cyclin D1; MCM7; Minichromosome Maintenance Complex Component 7; TRIM29; Tripartite Motif Containing 29; UBE2C; Ubiquitin-Conjuga
Keywords: MAPK; CP; caudate-putamen; CT; circadian time; DA; dopamine; DD; constant darkness; LD; lightdark cycle; MAPK; mitogen-activated protein kinase; NAcc; nucleus accumbens; Per; Period; PK2; Prokineticin 2; Ctx; cortex; OD; optical density; ORX; orexin; SCN; sup
Keywords: MAPK; GLN; glutamine; MEN; menadione; GSH; glutathione; SOD; superoxide dismutase; CAT; catalase; CB D28k; calbindin D28k; PMCA1b; plasma membrane Ca2+-ATPase; I/R; ischemia/reperfusion; ROS; reactive oxygen species; OD; optical density; DAB; 3,3â²-diaminobenz
Keywords: MAPK; Angiopoietin-like protein 2; Adipocyte; Osteoblast; Mesenchymal stem cell; Differentiation; ALP; alkaline phosphatase; AP2; adaptor protein 2; Angptl2; angiopoietin like protein 2; cDNA; complementary deoxyribonucleic acid; DMEM; Dulbecco's modified Eagle
Keywords: MAPK; A11; Melanoma; Melanocyte differentiation; MAPK; Akt; mitf;
Label-free quantitative phosphoproteomic profiling of cellular response induced by an insect cytokine paralytic peptide
Keywords: MAPK; PP; Paralytic peptide; LC-MS/MS; liquid chromatography-tandem mass spectrometry; TFs; transcription factors; PKs; protein kinases; KEGG; Kyoto Encyclopedia of Genes and Genomes; MAPK; mitogen-activated protein kinase; PAK; p21-activated kinase; GBP; growt
Keywords: MAPK; Gut-Kidney axis; Inflammation; Kidney injury; Short-chain fatty acids; AKI; acute kidney injury; βarrs; β-arrestins; cAMP; cyclic adenosine monophosphate; CKD; chronic kidney disease; CIN; contrast-induced nephropathy; ESRD; end-stage renal disease; E
Keywords: MAPK; HS; hemorrhagic shock; AKI; acute kidney injury; TBSA; total body surface area; GFR; glomerular filtration rate; BUN; blood urea nitrogen; RIFLE; Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease; ADQI; Acute Dialysis Quality Initia
Keywords: MAPK; ELISA; enzyme-linked immunosorbent assay; ERK; extracellular signal-regulated kinase; HMVEC; human dermal microvascular endothelial cell; HUVEC; human umbilical vein endothelial cell; IL-6; interleukin 6; IKK; IκB kinase; IP-10; interferon gamma-induced
Keywords: MAPK; AngII; angiotensin II; CKD; chronic kidney disease; EGF; epidermal growth factor; FGF; fibroblast growth factor; FGFR; fibroblast growth factor receptor; FRS2α; FGF receptor substrate 2α; HPG; heparan sulfate proteoglycans; IGF-1; insulin-like growth fa
Keywords: MAPK; Aza; 5-aza 2 deoxycytidine; TSA; trichostatin A; MeCP2; methyl CpG binding protein 2; SLE; systemic lupus erythematosus; RA; rheumatoid arthritis; DNMTs; DNA methyltransferases; HDACs; histone deacetylases; HAT; histones acetyl transferases; HMT; histone
Keywords: MAPK; AIPC; Androgen-independent prostate cancer; AKAP1; cAMP signaling; AML; acute myeloid leukemia; BAK; Bcl-2 homologous antagonist killer; BAX; Bcl-2-associated X protein; BCL-2; B-cell lymphoma 2; BMRP; BCL-2 interacting mitochondrial ribosomal protein; C7
Keywords: MAPK; PKA; protein kinase A; cAMP; cyclic AMP; CREB; cAMP response element binding; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; NMDA; N-methyl-D-aspartate receptor; CAMK; Ca2+-calmodulin-dependent protein kinase; BDNF; brain derived ne
Keywords: MAPK; Polyphenols; Antibiotics; Antioxidants; PACAP; Aβ; β-amyloid; AD; Alzheimer's disease; AMPK; AMP-activated protein kinase; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; CAT; catalase; CNS; central nervous system; COX-2; cyclooxyge
Keywords: MAPK; 1-OHP; 1-hydroxypyrene; 3-NT; 3-nitrotyrosine; 8-oxodGuo; 8-oxo-7,8-dihydro-2'-deoxyguanosine; 15-F2t-IsoP; 15-F2t-isoprostane; +dP/ dt; rate of change of pressure development; -dP/dt; rate of change of pressure decay; Ach; acetylcholine; p-AKT; phospho
Keywords: MAPK; AMPA; α-amino3-hydroxy-5-methyl-4-isoxazolepropionic acid; BBB; Blood brain barrier; BCAO; Bilateral ligation of common carotid arteries; CAT; Catalase; CBF; Cerebral blood flow; CCA; Common carotid artery; CNS; Central nervous system; COX-2; Cyclooxygen
Keywords: MAPK; Traumatic brain injury; Chronic traumatic encephalopathy; Tauopathy; Concussion; Repetitive head injury; 2-AG; 2-arachidonoylglycerol; 3-NT; 3-nitrotyrosine; 4-HNE; 4-hydroxynonenal; Ach; acetylcholine; AChEI; acetylcholine esterase inhibitor; AD; Alzheim
Keywords: MAPK; AAA; ATPases associated with diverse cellular activities; 17-AAG; 17-N-allylamino-17-demethoxygeldanamycin; ABC; ATP-binding cassette; ABCE1; ATP binding cassette subfamily E member 1; AD; Alzheimer's disease; AIF; apoptosis inducing factor; Akt; Alpha se
Keywords: MAPK; AA; Angelica Archangelica; AGNHW; AnGongNiuHuang Wan; AM; Astragalus membranaceus; AMP; adenosine monophosphate; AMPK; adenosine 5â²-monophosphate activated protein kinase; Ang II; angiotensin II; AP; Astragalus polysaccharide; ASIV; astragaloside IV; AS
Keywords: MAPK; ALS; acid-labile subunit; CIS; cytokine-inducible SH2-containing protein; E2; estradiol; ER; endoplasmic reticulum; ERK; extracelular regulated kinase; ESPE; European Society for Pediatric Endocrinology; GH; growth hormone; GHBP; growth hormone binding pr
Keywords: MAPK; Sphingosine-1-phosphate; Sphingosine kinase; Estradiol; Breast cancer; FTY720/Fingolimod; ERα; estrogen receptor α; EGFR; epidermal growth factor receptor; ERE; estrogen response element; ERK; extracellular signal regulated kinase; E2; 17β-estradiol; H
Keywords: MAPK; acupuncture; inflammation; JAK-STAT; NF-κB; MAPK;
Keywords: MAPK; ATM; ataxia telangiectasia mutated; DDR; DNA-damage response; MAPK; mitogen-activated protein kinase; MMP; matrix metalloproteinase; mTOR; mammalian target of rapamycin; PKD1; protein kinase D1; SASP; senescence-associated secretory phenotype; SCC; squamo
Keywords: MAPK; Cytoskeleton; MAPK; Apoptosis; Necrosis; Tissue engineering
Keywords: MAPK; Sepsis; Betulin; Inflammation; NF-κB; MAPK
Keywords: MAPK; [Ca++]i; intracellular Ca2+ concentration; 2ME2; 2-methoxyestradiol, a natural metabolite of estradiol; 4-OH-Tmx; 4-hydroxytamoxifen, a metabolite of Tmx; 5-HT3R; 5-hydroxytryptamine receptor subtype 3; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazolepropio
Keywords: MAPK; AA; arachidonic acid; COX-2; cyclooxygenase-2; DHAA; dihydroasparagusic acid; iNOS; inducible nitric oxide synthase; LOX; lipoxygenase; LPS; lipopolysaccharide; MAPK; mitogen activated protein kinase; NF-κB; nuclear factor-kB; NO; nitric oxide; PGE2; pro
Keywords: MAPK; DC; dendritic cell; ER; endoplasmic reticulum; IDO; indoleamine 2,3-dioxygenase; IFN-γ; interferon gamma; iNOS; inducible nitric oxide synthase; IRE1α; inositol-requiring enzyme 1 alpha; MAPK; mitogen-activated protein kinase; PD1; programmed death 1; P
Keywords: MAPK; Rosmarinic acid; Therapeutic; Allergic airway inflammation; AHR; NF-κB; MAPK;
Keywords: MAPK; Head and neck squamous cell carcinoma; Interleukin-6; JAK; STAT3; MAPK; PI3K/Akt; Nanog